{
    "clinical_study": {
        "@rank": "147991", 
        "arm_group": [
            {
                "arm_group_label": "Yoga", 
                "arm_group_type": "Experimental", 
                "description": "12 week session"
            }, 
            {
                "arm_group_label": "Cognitive Behavioral Therapy (CBT)", 
                "arm_group_type": "Active Comparator", 
                "description": "12 week session"
            }, 
            {
                "arm_group_label": "Stress Education", 
                "arm_group_type": "Sham Comparator", 
                "description": "12 week session"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this randomized study is to examine the comparative efficacy of yoga,\n      cognitive behavioral therapy, and stress education, a previously employed control condition,\n      for patients with Generalized Anxiety Disorder."
        }, 
        "brief_title": "GATE: Generalized Anxiety - A Treatment Evaluation", 
        "condition": "Generalized Anxiety Disorder", 
        "condition_browse": {
            "mesh_term": "Anxiety Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female outpatients > 18 years of age with a primary psychiatric diagnosis of\n             generalized anxiety disorder\n\n          -  Clinical Global Impression-Severity scale (CGI-S) score of 4 or higher\n\n          -  Off concurrent psychotropic medication for at least 2 weeks prior to initiation of\n             randomized treatment, OR stable on current medication for a minimum of 6 weeks and\n             willing to maintain a stable dose\n\n          -  Willingness and ability to perform the yoga intervention and to comply with the\n             requirements of the study protocol.\n\n          -  For women of childbearing potential, willingness to use a reliable form of birth\n             control\n\n        Exclusion Criteria:\n\n          -  Patients unable to understand study procedures and participate in the informed\n             consent process.\n\n          -  Pregnancy as assessed by pregnancy test at screen or lack of use approved methods\n             birth control for women of childbearing age\n\n          -  Women who are planning to become pregnant\n\n          -  Serious medical illness or instability for which hospitalization may be likely within\n             the next year\n\n          -  Significant current suicidal ideation or suicidal behaviors within the past 6 months\n             (assessed with the Beck Depression Inventory-II [BDI-II])\n\n          -  History of head trauma causing loss of consciousness, or seizure disorder resulting\n             in ongoing cognitive impairment\n\n          -  Posttraumatic stress disorder, substance use disorder, eating disorder, or organic\n             mental disorder within the past 6 months\n\n          -  Lifetime history of psychotic disorder, bipolar disorder, or developmental disorder\n\n          -  Significant personality dysfunction likely to interfere with study participation\n             (assessed during the clinical interview)\n\n          -  Prior experience with (more than 5 Yoga classes or CBT sessions within the last 3\n             years) and/or current practice of mindbody techniques (e.g., yoga, meditation,\n             Tai-Chi, etc) or cognitive behavioral therapy (CBT)\n\n          -  Concomitant therapy for generalized anxiety disorder (GAD) (any therapy)\n\n          -  Physical conditions that might cause injury from yoga (pregnancy, physical injuries\n             and musculoskeletal problems)\n\n          -  Cognitive impairment (MOCA<21)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "230", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01912287", 
            "org_study_id": "2013P000048", 
            "secondary_id": "1R01AT007258-01A1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cognitive Behavioral Therapy (CBT)", 
                "intervention_name": "Cognitive Behavioral Therapy", 
                "intervention_type": "Behavioral", 
                "other_name": "CBT"
            }, 
            {
                "arm_group_label": "Stress Education", 
                "intervention_name": "Stress Education", 
                "intervention_type": "Behavioral", 
                "other_name": "SE"
            }, 
            {
                "arm_group_label": "Yoga", 
                "intervention_name": "Yoga", 
                "intervention_type": "Behavioral", 
                "other_name": "Kundalini Yoga"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Generalized Anxiety Disorder", 
            "GAD", 
            "Yoga", 
            "CBT"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": [
            {
                "contact": {
                    "email": "acampbell7@partners.org", 
                    "last_name": "Allison Campbell", 
                    "phone": "617-726-3508"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }, 
                "investigator": {
                    "last_name": "Naomi M Simon, MD, MSc", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "slkind@bu.edu", 
                    "last_name": "Shelley Kind", 
                    "phone": "617-353-9610"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Boston University"
                }, 
                "investigator": {
                    "last_name": "Stefan G Hofmann, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "GATE: Generalized Anxiety - A Treatment Evaluation", 
        "overall_official": [
            {
                "affiliation": "Massachusetts General Hospital", 
                "last_name": "Naomi M Simon, MD, MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Boston University", 
                "last_name": "Stefan G Hofmann, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Treatment Response as Assessed by the Clinical Global Impression-Improvement (CGI-I of 1 or 2) scale", 
            "safety_issue": "No", 
            "time_frame": "Biweekly from weeks 0 through 12, and 6-month follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01912287"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Naomi M. Simon", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A)", 
            "safety_issue": "No", 
            "time_frame": "Weeks 0, 6 , 12 and 6 month follow up"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Center for Complementary and Alternative Medicine (NCCAM)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}